1Feleszko W,Zagozdzon R,Golab J,et al. Potentiated antitumor effects of cisplatin and lovastatin against MmB16 melanoma in mice[J].Eur J Cancer, 1998,34(3):406-411.
2Matar P,Rozados VR,Roggero EA,et al. Lovastatin inhibits tumor growth and metastasis development of a rat fibrosarcoma[J].Cancer-Biother-Radiopharm,1998,13(5):387-393.
3Li HY,Appelbaum FR,Willman CL,et al.Cholesterd-modulating agents kill acute myeloid leukemia cells and sensitize them to therpentics by blocking adaptive cholesterd responses[J].Blood,2003,101(9):3628-3634.
4Mueck AO,Seeger H,Wallwiener D. Effect of statins combined with estraiol on the proliferation of human receptor-positive and receptor-negative breast cancer cells[J].Menopause, 2003,10(4):332-336.
5Banke Agarwal,Balazs Halmos,Aleksander S, et al.Mechanism of lovastatin-induced apotosis in intesnalepithelial cells[J].Carcinogenesis,2002,23(3):521-528.
6Farina HG,Bublik DR,Alonso DF,et al. Lovastatin alters cytoskleton organization and inhibits experimental metastasis of mammary carcinoma cells[J].Clin-Exp-Metastasis,2002,19(6):551-559.
7Christophe Denoyelle,Marc Vasse,Marie Korner,et al. Cerivastatin,an inhibitor of HMG-CoA reductase,inhibits the signaling pathways invoved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines:an in vitro study[J].Carci
8Zukerbraum BS,Shapiro RA,Billiar TR,et al.RhoA influences the nuclear location of extracellular signal-regulated kinases to modulate p21Waf/Cipl expression[J].Circulation,2003,108(7):876-881.
9Cross TG, Scheel-Toelner D,Henriquez NV,et al. Sreine/threonine protein kinases and apoptosis[J].Exp Cell Res,2000,256(1):34-41.
10Holmstrom TH,Schmitz I,Soderstrom TS, et al, MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptasis downstream of DISC assembly[J].EMBO.J,2000,19(20):5418-5428.
二级参考文献11
1Wang IK, Lin-Shiau SY, Lin JK. Suppression of invasion and MMP-9 expression in NIH 3T3 and v-H-Ras 3T3 fibroblasts by lovastatin through inhibition of ras isoprenylation. Ontology, 2000, 59: 245-254.
2Agarwal B, Halmos B, Feoktistov AS, et al. Mechanism of lovastatin-induced apoptosis in intestinal epithelial cells. Carcinogenesis, 2002,23: 521-528.
3Shibata A, Nagaya T, Imai T, et al. Inhibition of NF-kappaB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells. Breast Cancer Res Treat, 2002, 73: 237-243.
4Birbach A, Gold P, Binder BR, et al. Signaling molecules of the NF-kappa B pathway shuttle constitutively between cytoplasm and nucleus. J Biol Chem, 2002, 277: 10842-10851.
5Gnad R, Kaina B, Fritz G. Rho GTPases are involved in the regulation of NF-kappaB by genotoxic stress. Exp Cell Res, 2001, 264: 244-249.
6Joyce D, Albanese C, Steer J, et al. NF-kappaB and cell-cycle regulation: the cyclin connection. Cytokine Growth Factor Rev, 2001,121 : 73-90.
7Namazie A, Alavi S, Olopade OI, et al. Cyclin D1 amplification and p16 (MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Laryngoscope, 2002, 112: 472-481.
8Li J, Tsai MD. Novel insights into the INK4-CDK4/6-Rb pathway:counter action of gankyrin against INK4 proteins regulates the CDK4-mediated phosphorylation of Rb. Biochemistry, 2002, 41 : 3977-3983.
9Martinez BJ, Ferroel A J, Suarez Y, et al. Dose-dependent effects of lovastatin on cell cycle progression: distinct requirement of cholesterol and non-sterol mevalonate derivatives. Biochim Biophys Acta, 2001,1532: 185-194.
10Natalia M, Arthur JK, Stephen FK, et al. Differential effects of Ras signaling through NF-кB on skeletal myogenesis. Oncogene, 2001, 20:1276-1286.
